Search - tctmd.com

Displaying 521 - 540 of 1751

Sort: Relevancy | Date

Top Stories in Cardiology, August 2017

Podcast Heart Sounds

Top Stories in Cardiology, August 2017

August 30, 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

August 29, 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

ESC Updates Guidelines for Treating STEMI Patients

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

August 27, 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

News Daily News

Hypertension, Underuse of Beta-Blockers Linked to Recurrent Tear in SCAD Patients

August 24, 2017

STEMI: Treatment Strategies, Drugs And Devices

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

Presentation

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

August 18, 2017

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

August 18, 2017

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

News Daily News

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

July 28, 2017

Management and Outcomes of STEMIin US Renal Transplant Recipients

Presentation

Management and Outcomes of STEMIin US Renal Transplant Recipients

July 28, 2017

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

July 20, 2017

Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition

News Daily News

Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition

July 17, 2017

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

News Daily News

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

July 04, 2017

TCTMD’s Top 10 Most Popular Stories for June 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

July 03, 2017

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

News Daily News

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

June 27, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.